Prospective feasible study for the postoperative urinastatin in patients with resectable lung cancer accompanied with interstitial pneumonitis
Phase 1
- Conditions
- interstitial pneumonitis lung cancer
- Registration Number
- JPRN-UMIN000006491
- Lead Sponsor
- Keio University School of Medicine, division of General Thoracic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
a)asbestosis b)Patients with interstitial pneumonitis caused by connective tissue disease c)chronic hypersensitivity pneumonitis d)sarcoidosis e)Patients who have the history of allergic reactions against urinastatin f)Patients who are pregnant or have possibility of pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ntil 1POM, we are going to judge clinically whether adverse outcomes happen, which is thought to be side-effects caused by postoperative ulinastatin therapy.
- Secondary Outcome Measures
Name Time Method